Kancera AB (Sweden) Analysis
| KAN Stock | SEK 1.06 0.04 3.92% |
Kancera AB is overvalued with Real Value of 0.96 and Hype Value of 1.03. The main objective of Kancera AB stock analysis is to determine its intrinsic value, which is an estimate of what Kancera AB is worth, separate from its market price. There are two main types of Kancera AB's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Kancera AB's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Kancera AB's stock to identify patterns and trends that may indicate its future price movements.
The Kancera AB stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Kancera AB is usually not traded on All Saints ' Day, St . John 's Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day, NationalDay. Kancera Stock trading window is adjusted to Europe/Stockholm timezone.
Kancera |
Kancera Stock Analysis Notes
About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kancera AB recorded a loss per share of 0.87. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 24th of February 2021. Kancera AB , a biotechnology company, engages in the development and sale of drug candidates to pharmaceutical companies in Sweden and internationally. The company was founded in 2010 and is based in Solna, Sweden. Kancera AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. To find out more about Kancera AB contact Thomas Olin at 46 8 50 12 60 80 or learn more at https://www.kancera.com.Kancera AB Investment Alerts
| Kancera AB generated a negative expected return over the last 90 days | |
| Kancera AB has high historical volatility and very poor performance | |
| Kancera AB has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 1.7 M. Net Loss for the year was (45.69 M) with profit before overhead, payroll, taxes, and interest of 1.7 M. | |
| Kancera AB has accumulated about 106.52 M in cash with (44.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders |
Kancera Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 262.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kancera AB's market, we take the total number of its shares issued and multiply it by Kancera AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 5th of February, Kancera AB secures the Mean Deviation of 5.21, standard deviation of 9.01, and Risk Adjusted Performance of (0.01). Kancera AB technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Kancera AB Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Kancera AB middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Kancera AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Kancera AB Outstanding Bonds
Kancera AB issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kancera AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kancera bonds can be classified according to their maturity, which is the date when Kancera AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Kancera AB Predictive Daily Indicators
Kancera AB intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Kancera AB stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Kancera AB Forecast Models
Kancera AB's time-series forecasting models are one of many Kancera AB's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kancera AB's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Kancera Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Kancera AB prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kancera shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kancera AB. By using and applying Kancera Stock analysis, traders can create a robust methodology for identifying Kancera entry and exit points for their positions.
Kancera AB , a biotechnology company, engages in the development and sale of drug candidates to pharmaceutical companies in Sweden and internationally. The company was founded in 2010 and is based in Solna, Sweden. Kancera AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Kancera AB to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Additional Tools for Kancera Stock Analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.